NEMESIS Citizen survey open!
📢 Take part in a European study and help us protect public health! Researchers from the NOVA National School of Public Health, in Portugal, as part of the NEMESIS project, are studying what people think about chemicals present in our daily lives to understand their needs and help improve public health measures. This study has […]
Understanding Mixture Risk Assessment: Why It Matters
When assessing chemical safety, most regulatory frameworks still evaluate substances individually. However, in our daily lives, we are environmentally exposed to a wide variety of substances – via the air we breath, the water we drink, the food we eat and the many consumer products we use every day. The NEMESIS project takes a crucial step forward […]
Using zebrafish to study metabolic adverse outcomes of EDCs and associated mechanisms
In October 2024, the Wincent Lab at Karolinska Institutet started testing the effects of NEMESIS focus-compounds on adverse outcomes using zebrafish, a non-mammalian model, as part of the in vivo work done in the NEMESIS project. Malin Lundvall, a Master’s student, and Oscar Diaz, Postdoc, performed the initial testing and evaluated the effects of 8 […]
NEMESIS project meeting in Barcelona 29-30 January 2025
NEMESIS has run for just over one year and it was time to see where the project is at. The consortium members met at a General Assembly meeting in Barcelona on 29-30 January 2025 to discuss the progress of the project and the next steps. The meeting was arranged at CSIC Spanish National Research Council […]
Subscribe the ENKORE newsletter
Subscribe now to receive in your inbox the ENKORE Cluster newsletter on the latest news and advances on the health impacts of endocrine-disrupting chemicals from European research institutions and five Horizon Europe funded projects: NEMESIS as well as EDC-MASLD, ENDOMIX, HYPIEND and MERLON. During the ENKORE cluster lifespan, just a total of three newsletters will be sent with cluster […]